Table 2 Characteristics of included cost-effectiveness analyses (n = 223)
Characteristic | Number | Percent |
|---|---|---|
Journals publishing | ||
1 paper | 60 | 61.2 |
2 papers | 17 | 17.3 |
3 papers | 6 | 6.1 |
4 papers or more | 15 | 15.3 |
Papers by source | ||
Journal articles | 206 | 92.4 |
Health technology assessment reports | 17 | 7.6 |
Papers by journal impact factor (JCR 2014) | ||
None | 88 | 39.5 |
0.1–2.0 | 61 | 27.3 |
2.1–5.0 | 58 | 26.0 |
5.1–10.0 | 12 | 5.4 |
>10.0 | 4 | 1.8 |
Papers by language of publication | ||
English | 127 | 57.0 |
Spanish | 96 | 43.0 |
Number of authors per paper | ||
1 | 3 | 1.3 |
2–3 | 33 | 14.8 |
4–7 | 143 | 64.8 |
≥8 | 44 | 19.7 |
Country of first author | ||
Spain | 183 | 82.1 |
UK | 8 | 3.6 |
USA | 7 | 3.1 |
Italy | 5 | 2.2 |
The Netherlands | 4 | 1.8 |
Sweden | 4 | 1.8 |
Other | 12 | 5.4 |
Focus of interventions | ||
Prevention | 18 | 8.1 |
Diagnosis/prognosis | 15 | 6.7 |
Treatment | 189 | 84.8 |
Rehabilitation | 1 | 0.4 |
Disease conditions | ||
Cardiovascular diseases | 47 | 21.1 |
Malignant neoplasms | 36 | 16.1 |
Infectious diseases | 31 | 13.9 |
Neurological and mental disorders | 30 | 13.4 |
Musculoskeletal disorders | 20 | 9.0 |
Other conditions | 59 | 26.5 |